ClinConnect ClinConnect Logo
Search / Trial NCT03292770

Mucus Removal Before Embryo Transfer

Launched by FUNDACION DEXEUS · Sep 21, 2017

Trial Information

Current as of May 29, 2025

Completed

Keywords

Embryo Transfer Flushing Catheter Pregnancy Rate Frozen Embryo Tranfer

ClinConnect Summary

ET involves placing the embryo(s) obtained before assisted reproduction technology (ART) into the uterus via a catheter advanced through the cervical canal. Yet this is the final, and in some respects the most critical, process in the sequential events that encompass an ART cycle. If an embryo cannot be delivered to the uterine cavity atraumatically and in a location for optimal implantation, the steps of ovarian hyperstimulation, oocyte retrieval, embryo culture, and embryo selection will have no benefit. Contamination of the catheter with blood may be a marker for difficult ET and has als...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • IVF or OD patients with supernumerary embryos (oocyte's age will be considered as patient's age).
  • Normal transvaginal ultrasound at screening, without evidence of clinically significant abnormality consistent with finding adequate for ART with respect to uterus and adnexa
  • Single embryo transfer
  • Embryo transfer at the blastocyst stage
  • Embryo with a morphological classification of ≥3BB
  • Exclusion Criteria:
  • Preimplantation genetic diagnosis and/or screening

About Fundacion Dexeus

Fundación Dexeus is a prominent clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative healthcare solutions. Based in Barcelona, Spain, the organization focuses on a wide range of therapeutic areas, particularly in women's health, reproductive medicine, and fertility. With a commitment to ethical practices and rigorous scientific methodologies, Fundación Dexeus collaborates with leading medical professionals and research institutions to conduct high-quality clinical trials. Their mission is to generate valuable data that informs clinical practices, enhances treatment options, and ultimately contributes to the betterment of healthcare globally.

Locations

Barcelona, , Spain

Patients applied

0 patients applied

Trial Officials

Jorge Rodriguez-Purata, MD

Principal Investigator

Hospital Universitario Dexeus

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials